Immune responses triggering colitis and colitis-associated carcinoma

被引:0
|
作者
Rebecca Kesselring
Stefan Fichtner-Feigl
机构
[1] Laboratory of Chronic Immunopathology,Department of Surgery
[2] University Medical Center Regensburg,undefined
来源
关键词
Colitis; Colitis-associated cancer; Immunology; Crohn's disease; Ulcerative colitis;
D O I
暂无
中图分类号
学科分类号
摘要
Inflammatory bowel diseases compromise of two forms of chronic intestinal inflammatory disorders: Crohn's disease and ulcerative colitis. Both forms of inflammatory bowel disease result from inappropriate inflammatory responses to the intestinal microbiota, but have different underlying immune responses. The connection between inflammation and cancer has long been established and longstanding inflammatory bowel diseases are an important risk factor for developing colorectal cancer. Colitis-associated colorectal cancer pathogenesis is highly influenced by specific inflammatory processes during inflammatory bowel disease. This article reviews the immunological responses affecting Crohn's disease and ulcerative colitis as well as the linkage of inflammatory bowel disease to the development of colitis-associated cancer. Finally, we discuss the prospects of using new research efforts to devise new immunotherapeutic approaches.
引用
收藏
页码:527 / 533
页数:6
相关论文
共 50 条
  • [1] Immune responses triggering colitis and colitis-associated carcinoma
    Kesselring, Rebecca
    Fichtner-Feigl, Stefan
    LANGENBECKS ARCHIVES OF SURGERY, 2012, 397 (04) : 527 - 533
  • [2] Innate immune mechanisms of colitis and colitis-associated colorectal cancer
    Saleh, Maya
    Trinchieri, Giorgio
    NATURE REVIEWS IMMUNOLOGY, 2011, 11 (01) : 9 - 20
  • [3] Innate immune mechanisms of colitis and colitis-associated colorectal cancer
    Maya Saleh
    Giorgio Trinchieri
    Nature Reviews Immunology, 2011, 11 : 9 - 20
  • [4] Endoscopic diagnosis of colitis-associated carcinoma
    Kiesslich, R.
    Neurath, M. F.
    GASTROENTEROLOGE, 2007, 2 (05): : 350 - 355
  • [5] Osteopontin in colitis-associated carcinoma (CAC)
    Manna, S.
    Sehn, M.
    da Silva, D. Cardoso
    Heldt, C.
    Horstkorte, L.
    Elezkurtaj, S.
    Siegmund, B.
    Weixler, B.
    Hummel, M.
    Groene, J.
    Schumann, M.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : I214 - I215
  • [6] Selenoprotein P in colitis-associated carcinoma
    Short, Sarah P.
    Whitten-Barrett, Caitlyn
    Williams, Christopher S.
    MOLECULAR & CELLULAR ONCOLOGY, 2016, 3 (03):
  • [7] COLON SPECIFIC ROLE FOR SELENOPROTEIN P IN COLITIS AND COLITIS-ASSOCIATED CARCINOMA
    Short, Sarah
    Pilat, Jennifer
    Reddy, Vishruth
    Haberman, Yael
    Hendren, Jared
    Washington, Mary
    Hyams, Jeffrey
    Denson, Lee
    Rosen, Michael
    Williams, Christopher
    INFLAMMATORY BOWEL DISEASES, 2021, 27 : S25 - S25
  • [8] Mechanisms of Immune Signaling in Colitis-Associated Cancer
    Waldner, Maximilian J.
    Neurath, Markus F.
    CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2015, 1 (01): : 6 - 16
  • [9] COLON SPECIFIC ROLE FOR SELENOPROTEIN P IN COLITIS AND COLITIS-ASSOCIATED CARCINOMA
    Short, Sarah
    Pilat, Jennifer
    Reddy, Vishruth
    Haberman, Yael
    Hendren, Jared
    Washington, Mary
    Hyams, Jeffrey
    Denson, Lee
    Rosen, Michael
    Williams, Christopher
    GASTROENTEROLOGY, 2021, 160 (03) : S32 - S33
  • [10] DAPK promotor hypermethylation in ulcerative colitis and colitis-associated colorectal carcinoma
    Kuester, D.
    Guenther, T.
    Hartmann, A.
    Tannapfel, A.
    Biesold, S.
    Bohr, U.
    Meyer, F.
    Bataille, F.
    Ruemmele, P.
    Lippert, H.
    Silver, A.
    Roessner, A.
    Schneider-Stock, R.
    PATHOLOGY RESEARCH AND PRACTICE, 2007, 203 (05) : 281 - 281